image 2 image 4
Skip Navigation Links
 Home 
 Congress Structure 
 Important Dates 
 Venue 
 Registration 
 Pre Registered 
 Abstracts 
 Scientific Program 
 Photo and Film Festival 
 Exhibition 
 Contact Us 
 Personal page 
       XXVIII Annual Congress of the Iranian Society of Ophthalmology        بـیــست و هشتمین کنــگــره سـالیـانه انـجـمـن چـشـم پـزشـکی ایـــران
مقاله Abstract


Title: Incidence and risk factors for post-intravitreal injection endophthalmitis in a modified operating room setting
Author(s): Mohammad Zarei, Reza Karkhaneh, Razieh Mahmoudzadeh, Mirataollah Salabati, Amin Nabavi, Mehdi Yaseri, Ehsan Najibzade, Ramak Roohipoor, Mohammad Riazi Esfahani, Alireza Khodabandeh, Fariba Ghassemi, Nazanin Ebrahimiadib, Hasan Khojasteh, Bobeck S. Modjtahedi
Presentation Type: Oral
Subject: Posterior Segment
Others:
Presenting Author:
Name: Mohamad Zarei
Affiliation :(optional) Farabi Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran
E mail: mzareiran@yahoo.com
Phone: 02155421113
Mobile: 09126063347
Purpose:

To evaluate the incidence and risk factors of post intravitreal injection (IVI) endophthalmitis in a single center modified operating room (OR) setting.

Methods:

In a Retrospective chart review patients who underwent IVI in a modified OR between September 2014 and November 2016 were included. Cases of post IVI endophthalmitis were identified from the Hospital Infection Control Committee records which tracks all post procedure infections.

Results:

51 472 IVIs (37 814 patients) including 13 658 bilateral simultaneous injections were performed during the study period. There were 17 cases of endophthalmitis (0.033%, 95% CI 0.019%-0.052%). There were no cases of bilateral endophthalmitis. Age, sex, indication for IVI, simultaneous bilateral injections, number of previous injections and type of injected drug were not significantly associated with incidence of endophthalmitis.

Conclusion:

Post IVI endophthalmitis is rare in this modified OR setting. Simultaneous bilateral IVIs and on-site preparation of injections are safe under these conditions.

Attachment:





Skip Navigation Links
        صفحه اصلی
        ساختار کنگره
        تاریخ های مهم
        مکان برگزاری
        ثبت نام
        ثبت نام شدگان
        اطلاعات هتل - رزرو
        مقالات
        برنامه کنگره
        جشنواره فیلم و عکس
        نمایشگاه
        تماس با ما
        صفحه شخصی
        جستجوی سخنران
        آرشیو کنگره سالهای گذشته
        شب کنگره چشم پزشکی
 
ورود شرکت کنندگان
نام کاربری :
کلمه عبور :
  کلمه عبور خود را فراموش کرده ام.
Total Visits
Find us on Social Media
Congress Count Down
Today Label
Last Month Label
Total Visitors Label